<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24623428</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Cell surface vimentin is an attachment receptor for enterovirus 71.</ArticleTitle><Pagination><StartPage>5816</StartPage><EndPage>5833</EndPage><MedlinePgn>5816-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.03826-13</ELocationID><Abstract><AbstractText Label="UNLABELLED">Enterovirus 71 (EV71) is a highly transmissible pathogenic agent that causes severe central nervous system diseases in infected infants and young children. Here, we reported that EV71 VP1 protein could bind to vimentin intermediate filaments expressed on the host cell surface. Soluble vimentin or an antibody against vimentin could inhibit the binding of EV71 to host cells. Accompanied with the reduction of vimentin expression on the cell surface, the binding of EV71 to cells was remarkably decreased. Further evidence showed that the N terminus of vimentin is responsible for the interaction between EV71 and vimentin. These results indicated that vimentin on the host cell surface may serve as an attachment site that mediated the initial binding and subsequently increased the infectivity of EV71.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">This study delivers important findings on the roles of vimentin filaments in relation to EV71 infection and provides information that not only improves our understanding of EV71 pathogenesis but also presents us with potentially new strategies for the treatment of diseases caused by EV71 infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Molecular Virology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Haolong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Hongchao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hua</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenliang</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Tien</LastName><ForeName>Po</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014746">Vimentin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025941" MajorTopicYN="N">Protein Interaction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014746" MajorTopicYN="N">Vimentin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="Y">Virus Attachment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24623428</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pii">JVI.03826-13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hagiwara A, Tagaya I, Yoneyama T. 1978. Epidemic of hand, foot and mouth disease associated with enterovirus-71 infection. Intervirology 9:60&#x2013;63. 10.1159/000148922</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148922</ArticleId><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9:1097&#x2013;1105. 10.1016/S1474-4422(10)70209-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardoso MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10:778&#x2013;790. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagaya I, Takayama R, Hagiwara A. 1981. A large-scale epidemic of hand, foot and mouth disease associated with enterovirus-71 infection in Japan in 1978. Jpn. J. Med. Sci. Biol. 34:191&#x2013;196</Citation><ArticleIdList><ArticleId IdType="pubmed">6273621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FGL, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, Jegathesan M, Anderson LJ, Grp OS. 2000. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin. Infect. Dis. 31:678&#x2013;683. 10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MT, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR, Taiwan Enterovirus Epidemic Working Group 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341:929&#x2013;935. 10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VTK. 2010. The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 14:E1076&#x2013;E1081. 10.1016/j.ijid.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. 2008. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol. 7:868&#x2013;869. 10.1016/S1474-4422(08)70207-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70207-2</ArticleId><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh KT, Doraisingham S, Tan JL, Lim GN, Chew SE. 1982. An outbreak of hand, foot, and mouth disease in Singapore. B World Health Organ. 60:965&#x2013;969</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2535982</ArticleId><ArticleId IdType="pubmed">6297819</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341:936&#x2013;942. 10.1056/NEJM199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo HM, Tan EL, Lee JJ, Ng JKW, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 86:2121&#x2013;2131. 10.1128/JVI.06103-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, Tsao KC, Liou GY, Huang ML, Hsia SH, Huang YC, Chang SC. 2010. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008 clinical, virologic, and serologic features. Pediatr. Infect. Dis. J. 29:1030&#x2013;1034. 10.1097/INF.0b013e3181e52945</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181e52945</ArticleId><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LCS, Wong KT, Lam SK, Chua KB, Goh AYT. 1998. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 352:1391. 10.1016/S0140-6736(05)60789-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)60789-1</ArticleId><ArticleId IdType="pubmed">9802304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. 2009. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 83:6477&#x2013;6483. 10.1128/JVI.00434-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi LN, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86:3767&#x2013;3776. 10.1128/JVI.06687-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Huang L, Gau SS, Wu Y, Hsia S, Fan T, Lin K, Huang Y, Lu C, Lin T. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356:1226&#x2013;1234. 10.1056/NEJMoa065954</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC. 2000. Enterovirus 71 infection and neurologic complications. Reply. N. Engl. J. Med. 342:357&#x2013;358. 10.1056/NEJM199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10660401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain KM, Leong KLJ, Ng MML, Chu JJH. 2011. The essential role of cathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J. Biol. Chem. 286:309&#x2013;321. 10.1074/jbc.M110.168468</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15:794&#x2013;797. 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li JF, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15:798&#x2013;801. 10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenpeck KL, Brummet ME, Hudson SA, Mayer RJ, Bochner BS. 2000. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J. Immunol. 165:2764&#x2013;2772</Citation><ArticleIdList><ArticleId IdType="pubmed">10946308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YC, Snapp K, Kansas GS, Camphausen R, Ding H, Luscinskas FW. 1998. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J. Immunol. 161:2501&#x2013;2508</Citation><ArticleIdList><ArticleId IdType="pubmed">9725249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma YQ, Plow EF, Geng JG. 2004. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alpha M beta 2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 104:2549&#x2013;2556. 10.1182/blood-2004-03-1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-03-1108</ArticleId><ArticleId IdType="pubmed">15217824</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. 2010. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 66:e1001174. 10.1371/journal.ppat.1001174</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Crombie R, Silverstein R. 1998. Lysosomal integral membrane protein II binds thrombospondin-1: structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. J. Biol. Chem. 273:4855&#x2013;4863. 10.1074/jbc.273.9.4855</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.9.4855</ArticleId><ArticleId IdType="pubmed">9478926</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega MA, Rodriguez F, Segui B, Cales C, Alcalde J, Sandoval IV. 1991. Targeting of lysosomal integral membrane-protein Limp-Ii&#x2014;the tyrosine-lacking carboxyl cytoplasmic tail of Limp-Ii is sufficient for direct targeting to lysosomes. J. Biol. Chem. 266:16269&#x2013;16272</Citation><ArticleIdList><ArticleId IdType="pubmed">1715864</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen EL, Tanaka Y, Saftig P. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137&#x2013;145. 10.1016/S0962-8924(03)00005-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(03)00005-9</ArticleId><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song ZL, Qi YH, Feng XF, Xu NQ, Sun YY, Wu X, Yao X, Mao QY, Li XL, Dong WJ, Wan XB, Huang N, Shen XL, Liang ZL, Li WH. 2012. Molecular determinants of enterovirus 71 viral entry cleft around Gln-172 on Vp1 protein interacts with variable region on scavenge receptor B2. J. Biol. Chem. 287:6406&#x2013;6420. 10.1074/jbc.M111.301622</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S. 2012. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 86:5686&#x2013;5696. 10.1128/JVI.00020-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional Comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 87:3335&#x2013;3347. 10.1128/JVI.02070-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. 2009. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 6:141. 10.1186/1743-422X-6-141</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 85:11809&#x2013;11820. 10.1128/JVI.00297-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman RD, Khuon S, Chou YH, Opal P, Steinert PM. 1996. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol. 134:971&#x2013;983. 10.1083/jcb.134.4.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.4.971</ArticleId><ArticleId IdType="pmc">PMC2120965</ArticleId><ArticleId IdType="pubmed">8769421</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Ravi V, Desai A. 2011. Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 160:404&#x2013;408. 10.1016/j.virusres.2011.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JK, Fahad AM, Shanmukhappa K, Kapil S. 2006. Defining the cellular target (s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J. Virol. 80:689&#x2013;696. 10.1128/JVI.80.2.689-696.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.2.689-696.2006</ArticleId><ArticleId IdType="pmc">PMC1346842</ArticleId><ArticleId IdType="pubmed">16378972</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimstra WB, Ryman KD, Johnston RE. 1998. Adaptation of sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357&#x2013;7366</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109960</ArticleId><ArticleId IdType="pubmed">9696832</ArticleId></ArticleIdList></Reference><Reference><Citation>Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. 2009. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog. 5:e1000417. 10.1371/journal.ppat.1000417</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000417</ArticleId><ArticleId IdType="pmc">PMC2670497</ArticleId><ArticleId IdType="pubmed">19412526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WC, Fuller AO. 1993. Herpes-simplex virus type-1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan-sulfate. J. Virol. 67:5088&#x2013;5097</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237906</ArticleId><ArticleId IdType="pubmed">8394437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedellec P, Vicart P, Laurent-Winter C, Martinat C, Prevost MC, Brahic M. 1998. Interaction of Theiler's virus with intermediate filaments of infected cells. J. Virol. 72:9553&#x2013;9560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110461</ArticleId><ArticleId IdType="pubmed">9811688</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan TT, Qin B, Guo L, Lei XB, Wang JW, Wang MT, Jin Q. 2011. Crystal structure of human enterovirus 71 3C protease. J. Mol. Biol. 408:449&#x2013;461. 10.1016/j.jmb.2011.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Alonso S, Chow VTK, Poh CL. 2007. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 9:1299&#x2013;1306. 10.1016/j.micinf.2007.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2007.06.002</ArticleId><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca VC, AbiMansour J, Nelson CA, Fremont DH. 2012. Crystal structure of the Japanese encephalitis virus envelope protein. J. Virol. 86:2337&#x2013;2346. 10.1128/JVI.06072-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06072-11</ArticleId><ArticleId IdType="pmc">PMC3302414</ArticleId><ArticleId IdType="pubmed">22156523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Nakamura F, Lee W, Shifrin Y, Arora P, McCulloch CA. 2010. Filamin A is required for vimentin-mediated cell adhesion and spreading. Am. J. Physiol. Cell Physiol. 298:C221&#x2013;C236. 10.1152/ajpcell.00323.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00323.2009</ArticleId><ArticleId IdType="pmc">PMC4380480</ArticleId><ArticleId IdType="pubmed">19776392</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakova S, Choi BY, Choi HS, Kang BS, Bode AM, Dong ZG. 2005. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 280:16882&#x2013;16890. 10.1074/jbc.M414185200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414185200</ArticleId><ArticleId IdType="pubmed">15713670</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Guo MS, Lin FHY, Hsiao KN, Chang KHW, Chou AH, Wang YC, Chen YC, Yang CS, Chong PCS. 2011. Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system. PLoS One 6:e20005. 10.1371/journal.pone.0020005</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020005</ArticleId><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong HL, Jiang Y, Tien P. 2011. Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus. J. Virol. 85:11038&#x2013;11047. 10.1128/JVI.05398-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05398-11</ArticleId><ArticleId IdType="pmc">PMC3194935</ArticleId><ArticleId IdType="pubmed">21880773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi XY, Lei XB, Zhang XY, Cui S, Wang JW, Jin Q, Zhao ZD. 2013. Enterovirus 71 protease 2A(pro) targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 9:e1003231. 10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Li GD, Zhang YQ, Liu XM, Tien P. 2012. A novel minicircle vector based system for inhibiting the replication and gene expression of enterovirus 71 and coxsackievirus A16. Antiviral Res. 96:234&#x2013;244. 10.1016/j.antiviral.2012.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.08.003</ArticleId><ArticleId IdType="pubmed">22921338</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. 2013. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Nat. Acad. Sci. U. S. A. 110:5463&#x2013;5467. 10.1073/pnas.1222379110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H. 2011. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J. Gen. Virol. 92:287&#x2013;291. 10.1099/vir.0.022418-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, Phuektes P, McMinn P. 2012. Mouse adaptation of a subgenogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res. 167:86&#x2013;96. 10.1016/j.virusres.2012.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.04.009</ArticleId><ArticleId IdType="pubmed">22575826</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. 2012. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422:132&#x2013;143. 10.1016/j.virol.2011.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mettenleiter TC. 2002. Brief overview on cellular virus receptors. Virus Res. 82:3&#x2013;8. 10.1016/S0168-1702(01)00380-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(01)00380-X</ArticleId><ArticleId IdType="pubmed">11885946</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider-Schaulies J. 2000. Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 81:1413&#x2013;1429</Citation><ArticleIdList><ArticleId IdType="pubmed">10811925</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. 2006. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell Biol. 8:156&#x2013;162. 10.1038/ncb1355</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1355</ArticleId><ArticleId IdType="pubmed">16429129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH. 2012. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One 7:e30507. 10.1371/journal.pone.0030507</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 85:4937&#x2013;4946. 10.1128/JVI.02358-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. 2008. Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 82:1787&#x2013;1797. 10.1128/JVI.01798-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. 2008. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89:1622&#x2013;1632. 10.1099/vir.0.83676-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Shimizu H, Nishimura Y, Arita M, Shamala D, Cardosa MJ, Wong KT. 2008. Phenotypic and genotypic characterization of two mouse adapted enterovirus 71 strains that showed differences in murine CNS infection. Int. J. Infect. Dis. 12:E74&#x2013;E74. 10.1016/j.ijid.2008.05.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2008.05.186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78:7916&#x2013;7924. 10.1128/JVI.78.15.7916-7924.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyatina AA, Nicolet S, Aebi U, Herrmann H, Strelkov SV. 2012. Atomic structure of the vimentin central alpha-helical domain and its implications for intermediate filament assembly. Proc. Natl. Acad. Sci. U. S. A. 109:13620&#x2013;13625. 10.1073/pnas.1206836109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206836109</ArticleId><ArticleId IdType="pmc">PMC3427084</ArticleId><ArticleId IdType="pubmed">22869704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann H, Haner M, Brettel M, Muller S, Goldie KN, Fedtke B, Lustig A, Franke WW, Aebi U. 1996. Structure and assembly properties of intermediate filament protein vimentin: the role of its head, rod and tail domains. Mol. Biol. Cell 264:933&#x2013;953</Citation><ArticleIdList><ArticleId IdType="pubmed">9000622</ArticleId></ArticleIdList></Reference><Reference><Citation>Traub P, Scherbarth A, Wiegers W, Shoeman RL. 1992. Salt-stable interaction of the amino-terminal head region of vimentin with the alpha-helical rod domain of cytoplasmic intermediate filament proteins and its relevance to protofilament structure and filament formation and stability. J. Cell Sci. 101:363&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pubmed">1629250</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>